FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
2023 iCAN Summit
Join us for an unforgettable experience at the 2023 iCAN Summit! We are excited to announce that our CEO, as a member [...]
Lecture on Pharmacovigilance in Paediatric Clinical Trials at University of Pavia
Mariagrazia Felisi, our Quality Assurance Head, recently delivered an insightful lecture on "Pharmacovigilance in Paediatric Clinical Trials: Regulatory Foundations, Paediatric Considerations and [...]
Standardizing Paediatric Clinical Data: The Development of the conect4children (c4c) Cross Cutting Paediatric Data Dictionary
Paediatric clinical trials face several challenges, such as developing age-specific formulations and dosages, complying with regulatory requirements, ethical considerations, and the need [...]
European Research and Innovation Days 2022
The European Research and Innovation Days will take place online on 28 and 29 September 2022, allowing everyone to get [...]
Scientific publication: Ensuring a future for gene therapy for rare diseases
The paper “Ensuring a future for gene therapy for rare diseases” by Alessandro Aiuti, Francesca Pasinelli, and Luigi Naldini has [...]
Mitochondrial Diseases Conference 2022
The 2022 Mitochondrial Diseases Conference, organized by Mitocon, will be held on 7th – 9th October at the Holiday Inn [...]
The IRDiRC State of Play Report 2019 – 2021
The International Rare Diseases Research Consortium (IRDiRC) Rare Diseases Research Initiatives State of Play 2019-2021 Report has been recently published. [...]
CVBF answered to the Public Consultation: Pharmaceuticals – safe and affordable medicines (new EU strategy)
The European Commission is launching a new strategy to improve and accelerate patients’ access to safe and affordable medicines and to support innovation in the [...]
CVBF is involved with the University of Pittsburgh in developing two vaccines for the coronavirus disease
We are glad to inform you that Consorzio per Valutazioni Biologiche e Farmacologiche will provide its contribution in the fight against COVID-19 emergency. It was [...]
COVID-19: EMA sets up infrastructure for real-world monitoring of treatments and vaccines
EMA has now set up an infrastructure to support the monitoring of the efficacy and safety of COVID-19 treatments and vaccines when used in day-to-day [...]
CVBF is involved in the multinational cASPerCF clinical trial
In the framework the c4c IMI2 funded project (pan European paediatric clinical trials network) cASPerCF study will be carried out. The study is being led [...]
CVBF has just overcome a GCP audit by AIFA, the Italian Medicines Agency
Since 2002 CVBF has been acting as Sponsor and Clinical Research Organisation (CRO) involved in clinical trial execution and it is currently ready to provide [...]
Public Consultation on Good Lay Summary Practice and the Roadmap Initiative
The European Medicines Agency (EMA) released an Expert Group Recommendation on the content of Lay Summaries of clinical study results from commercial and non-commercial sponsors. [...]